Nanotechnology Based Topical Insulin Delivery System: Promising Role in Diabetic Wound Healing

Area of Science:

• Biomedical Science
• Wound Healing Research
• Diabetes Complications

Background:

• Diabetes mellitus is a chronic metabolic disorder leading to impaired wound healing, especially in diabetic foot ulcers (DFUs).
• Pathological factors include hyperglycemia, oxidative stress, neuropathy, immune dysfunction, and impaired angiogenesis.
• DFUs present a significant risk for chronic inflammation and amputation.

Purpose of the Study:

• To explore topical insulin as a therapeutic strategy for accelerating diabetic wound repair.
• To investigate the role of nanotechnology-based drug delivery systems (DDSs) in enhancing insulin efficacy for diabetic wounds.
• To highlight future research directions for optimizing diabetic wound management.

Main Methods:

• Review of current therapeutic approaches for diabetic wound healing.
• Analysis of insulin's mechanisms in glucose metabolism, angiogenesis, and cellular repair.
• Examination of nanotechnology-based DDSs for targeted and sustained insulin delivery.

Main Results:

• Topical insulin demonstrates potential in regulating glucose metabolism and stimulating cellular repair mechanisms.
• Nanotechnology-based DDSs improve insulin's targeted delivery, efficacy, and controlled release at wound sites.
• These advancements foster rapid and efficient tissue regeneration in diabetic wound models.

Conclusions:

• Topical insulin, particularly when delivered via nanotherapeutics, offers a promising avenue for managing diabetic wounds.
• Optimized formulations and personalized treatment approaches are crucial for clinical translation.
• Further research and clinical validation could significantly improve outcomes for diabetic patients with chronic wounds.